MedTrace Logo

Minimally Invasive Pancreatoduodenectomy for Distal Cholangiocarcinoma

NCT05478889 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 478

Last updated 2022-07-28

No results posted yet for this study

Summary

Outcomes for minimally invasive and open pancreatoduodenectomy for distal cholangiocarcinoma have not been compared. This is an international multicenter propensity score matched cohort study including patients after MIPD or OPD for dCCA. Primary outcomes included overall survival (OS) and disease-free interval (DFI).

Conditions

  • Distal Cholangiocarcinoma

Interventions

PROCEDURE

Minimally invasive pancreatoduodenectomy

Whipple's procedure using minimally invasive (laparoscopic/robotic) techniques

Sponsors & Collaborators

  • Fondazione Poliambulanza Istituto Ospedaliero

    lead OTHER

Principal Investigators

  • Moh'd Abu Hilal, MD, PhD · Fondazione Poliambulanza

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-03-01
Completion
2022-07-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05478889 on ClinicalTrials.gov